Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endobiotics for Phenotyping CYP2C19
NCT07014930Phase 1Recruiting
- Start
- Dec 2024
- Primary completion
- Nov 2025
- Countries
- 1
01
Overview
Phase 1, open-label trial (2 arms). Primary endpoint: Fold-change in the intensities of features determined by mass spectrometry at Day 27. Started Dec 2024; status: recruiting.
Beyond the preview
Go deeper on NCT07014930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07014930.